Małgorzata B. Różanowska
Jennifer J. Hunter- 1Cardiff Institute of Tissue Engineering and Repair, Cardiff University, Wales, United Kingdom
- 2School of Optometry and Vision Sciences, Cardiff University, Cardiff, Wales, United Kingdom
- 3School of Optometry and Vision Science, University of Waterloo, Waterloo, ON, Canada
Editorial on the Research Topic
Diagnostic and therapeutic applications of visible and near-infrared light for the retina
Visible and near infrared (NIR) light is utilised in many applications to help diagnose, monitor progression, and/or treat various diseases and retinal conditions. Diagnostic imaging techniques include optical coherence tomography (OCT) and scanning laser ophthalmoscopy (SLO). These rely on visible or near-infrared (NIR) light reflected from the structures of the retina because of variations in their refractive indices across different cellular layers. SLO is a point-scanning system, similar to a confocal microscope, that provides en face images of the structures at the back of the eye. Typically, it uses a laser to provide monochromatic exposure to visible and NIR wavelengths ranging from 488 nm to 830 nm, and can be combined with many different imaging modalities, including fluorescence (1–3). In OCT, reflected light of the bandwidths of 40 to 150 nm, typically in 750-900 nm or 1000–1100 nm range, interacts with a reference beam, creating interference patterns that can be decoded into the amplitude and retinal depth of the reflected light, revealing retinal structure at an axial resolution of a few micrometres (4–6).
In this Research Topic, Allegrini et al. described using OCT and NIR reflectance funduscopy to monitor the progression of tangential traction associated with epiretinal membranes (ERMs). Fundus tracking was employed to co-localise the OCT and reflectance images, from which 10 vessel crossings were manually selected. These vessel crossings were then followed up during subsequent examinations, which took place one week before and one month after the peeling surgery. OCT B-scans were used to segment the ERM and the retinal pigment epithelium (RPE), and to determine the vertical projections of each vessel crossing onto the ERM/inner limiting membrane (ILM) and the RPE. The vertical projection of the vessel crossing onto the RPE, as recorded one month after surgery, served as a reference point for measuring the horizontal shift of crossings, as determined by the B-scan in the previous examinations – this is defined as the relaxation index (RI). Measurements performed on 9 eyes of 9 patients demonstrated that there was a statistically significant increase in RI between the initial examination and the examination one week before the surgery, and that there was a statistically significant decrease in RI between the examinations before the surgery and those taking place one month post-surgery, suggesting that RI can be used as an objective parameter to measure the ERM traction and relaxation after surgical removal.
Intensity-based optoretinography (iORG) measures changes in the amplitude of back-scattered/reflected light from photoreceptors after a light stimulus (7–9). Gaffney et al. used iORG with adaptive optics SLO (AOSLO) and microperimetry to investigate the structural and functional changes in cones in 7 retinas affected by retinitis pigmentosa (RP), comparing them with 15 healthy retinas. Using imaging with a low coherence superluminescent diode as the light source, which emitted in the NIR spectrum, the authors determined that the nearest neighbour distance (NND) of cones was largest in patients with RP across different retinal eccentricities. iORG amplitudes recorded in response to photoexcitation with 66-ms pulses of visible light showed that the majority of cones in RP patients demonstrated decreased amplitudes compared with cones in healthy retinas. Using OCT, they recorded longitudinal reflectivity profiles (LRPs), from which the length of the cone outer segment was determined to be shorter in RP cones than in normal cones. Importantly, it was demonstrated that iORG is more sensitive than microperimetry in the detection of functional deficits in cones at the early stages of RP.
Visible and NIR light is also employed for various therapeutic purposes, which include photobiomodulation (PBM). Using narrow-band light (usually within the 600–1100 nm range), PBM targets endogenous chromophores to improve some aspects of retinal health and function. Valter et al. provided a brief overview of preclinical studies, clinical case studies, and clinical trials that tested PBM for different retinal and other ocular conditions, including retinopathy of prematurity, RP, Stargardt’s disease, Leber’s hereditary optic neuropathy, diabetic retinopathy, diabetic macular oedema, age-related macular degeneration, amblyopia, myopia, corneal trauma, keratitis, and hydroxyapatite orbital implant exposure. The safety aspects were discussed briefly, primarily in terms of safety for tissues other than the retina. However, in the majority of reports from clinical trials, the exposure parameters provided in publications are not sufficient to evaluate retinal irradiance and compare radiant exposure with the safety thresholds established for ophthalmic devices with respect to retinal susceptibility to light-induced injury (10). A device used for the treatment of myopia, which emits a 654 nm wavelength with a power of 0.2 mW through an aperture of 7 mm in diameter, was found to exceed the photochemical and photothermal safety limits within 34 and 33 s of exposure, respectively (11, 12). However, children using these devices are instructed to look directly into the beam for 180 s twice a day, 5 days a week, for several years. While the safety aspects of PBM for myopia control have been questioned (11–15), resulting in manufacturers of PBM devices being required to provide thorough safety evaluations, including primate trials, before any further clinical trials can be approved in China (16), the irradiance levels used for the treatment of age-related macular degeneration (AMD) and other retinal conditions are several orders of magnitude greater than those used for myopia, therefore raising serious concerns about their photochemical and photothermal safety for the retina. Table 1, provided by Valter et al., lists clinical trials of PBM for AMD, in which five trials used 5-minute exposures to a combination of 590 nm yellow light of 5 mW/cm2 irradiance, 660 nm red light of 65 mW/cm2 irradiance and 850 nm NIR light of 8 mW/cm2 irradiance. These exposures are highly likely to greatly exceed the retinal safety thresholds for thermal and photochemical injuries, but the evaluation of retinal irradiance from these devices has not yet been reported. It is worth considering that, while several hypothetical scenarios have been proposed to explain the observed beneficial effects of PBM (17, 18), the mechanisms involved remain unclear. Furthermore, there has been no systematic investigation into the optimal wavelength, irradiance, exposure duration, or frequency of repetition. This is important because a recent study indicates that the beneficial effects of PBM on visual acuity in AMD patients can be achieved with ten 10-minute exposures to only 15 µW red light incident on the cornea (19).
Finally, the interaction of light with RPE cells was considered. Denton et al. used mathematical modelling to examine photochemical and photothermal types of damage in relation to pigmented RPE cells in vitro. Pope et al. demonstrated in vitro that the light exposure that elevates the temperature of RPE cells exacerbates photochemical damage. These studies will have an impact on understanding and predicting damage thresholds and mechanisms in the human retina.
Author contributions
MR: Writing – original draft, Writing – review & editing. JH: Writing – review & editing.
Conflict of interest
The authors declare a potential conflict of interest and state it below: JH has a patent pending related to imaging technology through the University of Rochester.
The remaining author declared that that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors declared that MR was an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The authors declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Fischer J, Otto T, Delori F, Pace L, and Staurenghi G. Scanning laser ophthalmoscopy (SLO). In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics. Springer, Cham (CH (2019).
2. Terasaki H, Sonoda S, Tomita M, and Sakamoto T. Recent advances and clinical application of color scanning laser ophthalmoscope. J Clin Med. (2021) 10:718. doi: 10.3390/jcm10040718
3. Mainster MA, Desmettre T, Querques G, Turner PL, and Ledesma-Gil G. Scanning laser ophthalmoscopy retroillumination: applications and illusions. Int J Retina Vitreous. (2022) 8:71. doi: 10.1186/s40942-022-00421-0
4. Drexler W and Fijimoto JG eds. Optical coherence tomography: technology and applications. Berlin: Springer (2008).
5. Wojtkowski M, Kaluzny B, and Zawadzki RJ. New directions in ophthalmic optical coherence tomography. Optom Vis Sci. (2012) 89:524–42. doi: 10.1097/OPX.0b013e31824eecb2
6. Mrejen S and Spaide RF. Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol. (2013) 58:387–429. doi: 10.1016/j.survophthal.2012.12.001
7. Lassoued A, Zhang F, Kurokawa K, Liu Y, Bernucci MT, Crowell JA, et al. Cone photoreceptor dysfunction in retinitis pigmentosa revealed by optoretinography. Proc Natl Acad Sci U.S.A. (2021) 118:e2107444118. doi: 10.1073/pnas.2107444118
8. Kim TH, Ma G, Son T, and Yao X. Functional optical coherence tomography for intrinsic signal optoretinography: recent developments and deployment challenges. Front Med (Lausanne). (2022) 9:864824. doi: 10.3389/fmed.2022.864824
9. Jonnal RS. Toward a clinical optoretinogram: a review of noninvasive, optical tests of retinal neural function. Ann Transl Med. (2021) 9:1270. doi: 10.21037/atm-20-6440
10. American National Standards Institute. Z136.1–2022 American National Standard for Safe Use of Lasers. New York: American National Standards Institute (2022).
11. Ostrin LA and Schill AW. Red light instruments for myopia exceed safety limits. Ophthalmic Physiol Opt. (2024) 44:241–8. doi: 10.1111/opo.13272
12. Ostrin LA and Schill AW. Response to letter to the editor. Ophthalmic Physiol Opt. (2024) 44:674–7. doi: 10.1111/opo.13296
13. Schaeffel F and Wildsoet CF. Red light therapy for myopia: Merits, risks and questions. Ophthalmic Physiol Opt. (2024) 44:801–7. doi: 10.1111/opo.13306
14. Richards J, Hunter JJ, Gantes-Nuñez J, Bradley A, and Kollbaum P. Radiometric and safety assessment of a ‘low-level red-light’ myopia control device. Ophthalmic Physiol Opt. (2025) 00:1–7. doi: 10.1111/opo.70009
15. Liao X, Yu J, Fan Y, Zhang Y, Li Y, Li X, et al. Cone density changes after repeated low-level red light treatment in children with myopia. JAMA Ophthalmol. (2025) 143:480–8. doi: 10.1001/jamaophthalmol.2025.0835
16. Wang YX, Wang N, and Wong TY. Red light therapy for myopia-current regulatory changes in China. JAMA Ophthalmol. (2025) 143:197–8. doi: 10.1001/jamaophthalmol.2024.5977
17. Beirne K, Rozanowska M, and Votruba M. Photostimulation of mitochondria as a treatment for retinal neurodegeneration. Mitochondrion. (2017) 36:85–95. doi: 10.1016/j.mito.2017.05.002
18. Kashiwagi S, Morita A, Yokomizo S, Ogawa E, Komai E, Huang PL, et al. Photobiomodulation and nitric oxide signaling. Nitric Oxide. (2023) 130:58–68. doi: 10.1016/j.niox.2022.11.005
Keywords: adaptive optics scanning light ophthalmoscopy (AOSLO), light-induced retinal injury, ophthalmic imaging techniques, optical coherence tomography (OCT), optoretinography, photobiomodulation
Citation: Różanowska MB and Hunter JJ (2025) Editorial: Diagnostic and therapeutic applications of visible and near-infrared light for the retina. Front. Ophthalmol. 5:1743468. doi: 10.3389/fopht.2025.1743468
Received: 10 November 2025; Accepted: 08 December 2025; Revised: 03 December 2025;
Published: 18 December 2025.
Edited and reviewed by:
Winfried Amoaku, University of Nottingham, United KingdomCopyright © 2025 Różanowska and Hunter. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Małgorzata B. Różanowska, cm96YW5vd3NrYW1iQGNhcmRpZmYuYWMudWs=; Jennifer J. Hunter, amVubmlmZXIuaHVudGVyQHV3YXRlcmxvby5jYQ==